Ketai Bio Funding: $73M Raised, Series B (2023)

Ketai Bio is based in Shanghai, China. It has raised $73M in total funding. Latest round: Series B.

Ketai Bio funding overview

Ketai Bio is based in Shanghai, China. Ketai Bio has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2023. The round record for Ketai Bio runs through 2023; nothing later has been disclosed. Investors on record include Eight Roads Ventures, Hengxu Capital, Sequoia China, F-Prime Capital, Source Code, Bits x Bites and 2 others. 8 distinct backers are named across the disclosed rounds.

Ketai Bio at a glance

Total raised
$73M
Latest round
Series B
Latest round date
September 2023
Headquarters
Shanghai, China
Notable investors
Eight Roads Ventures, Hengxu Capital, Sequoia China, F-Prime Capital, Source Code, Bits x Bites, Henan Huirong, Yuanqi Capital

Frequently asked about Ketai Bio funding

How much has Ketai Bio raised?
Ketai Bio has raised $73M in total disclosed funding across the rounds on record.
Who has invested in Ketai Bio?
Eight Roads Ventures, Hengxu Capital, Sequoia China, F-Prime Capital, Source Code, Bits x Bites are named among the investors backing Ketai Bio.
What was the latest Ketai Bio funding round?
The most recent disclosed round is a Series B, announced in September 2023.
Where is Ketai Bio based?
Ketai Bio is based in Shanghai, China.
When did Ketai Bio last raise?
The last disclosed Ketai Bio round closed in September 2023 at Series B.

Round data for Ketai Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

Companies related to Ketai Bio (36)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026